[go: up one dir, main page]

MA26543A1 - PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS. - Google Patents

PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS.

Info

Publication number
MA26543A1
MA26543A1 MA25243A MA25243A MA26543A1 MA 26543 A1 MA26543 A1 MA 26543A1 MA 25243 A MA25243 A MA 25243A MA 25243 A MA25243 A MA 25243A MA 26543 A1 MA26543 A1 MA 26543A1
Authority
MA
Morocco
Prior art keywords
elastase inhibitors
neutrophilic elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
MA25243A
Other languages
French (fr)
Inventor
Geoffrey Duke Edward Clarke
Graham George Adam Inglis
Michael Dennis Dowle
Martin Redpath Johnson
Harry Finch
Simon John Fawcett Macdonald
Lee Andrew Harrison
Pritom Shah
Robin Andrew Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26543A1 publication Critical patent/MA26543A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
MA25243A 1997-09-09 1998-09-07 PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS. MA26543A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds

Publications (1)

Publication Number Publication Date
MA26543A1 true MA26543A1 (en) 2004-12-20

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25243A MA26543A1 (en) 1997-09-09 1998-09-07 PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS.

Country Status (24)

Country Link
EP (1) EP1003748A2 (en)
JP (1) JP2001515904A (en)
KR (1) KR20010023766A (en)
CN (1) CN1278820A (en)
AP (1) AP2000001761A0 (en)
AR (1) AR017072A1 (en)
AU (1) AU9741298A (en)
BR (1) BR9812062A (en)
CA (1) CA2303176A1 (en)
CO (1) CO4970719A1 (en)
EA (1) EA200000204A1 (en)
EE (1) EE200000138A (en)
HU (1) HUP0004644A3 (en)
ID (1) ID24452A (en)
IL (1) IL134791A0 (en)
IS (1) IS5391A (en)
MA (1) MA26543A1 (en)
NO (1) NO20001198L (en)
NZ (1) NZ503130A (en)
PE (1) PE107899A1 (en)
PL (1) PL339176A1 (en)
SK (1) SK3192000A3 (en)
TR (1) TR200000907T2 (en)
WO (1) WO1999012933A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
WO2005096734A2 (en) 2004-03-31 2005-10-20 Janssen Pharmaceutica, N.V. Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
DE102004024772A1 (en) 2004-05-17 2005-12-22 Grünenthal GmbH Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides
JP4853759B2 (en) * 2004-05-27 2012-01-11 日本農薬株式会社 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates thereof, agricultural and horticultural agents, and methods of use thereof
TWI355380B (en) * 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ATE439347T1 (en) 2004-11-23 2009-08-15 Warner Lambert Co 7-(2H-PYRAZOLE-3-YL)-3,5-DIHYDROXY-HEPTANIC ACID DERIVATIVES AS HMG-CO-A-REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
DE602007009095D1 (en) 2006-05-04 2010-10-21 Pulmagen Therapeutics Inflamma TETRAHYDROPYRROLOPYRIMIDINDIONE AND ITS USE AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
DK4106757T3 (en) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd METHODS INVOLVING THE NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR THE TREATMENT OF AIRWAY DISEASE MEDIATED BY ALPHA-1-ANTITRYPSIN DEFICIENCY
CN118265527A (en) 2021-10-20 2024-06-28 美莱奥生物制药第四有限公司 Neutrophil elastase inhibitors for the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
ATE261969T1 (en) * 1996-03-28 2004-04-15 Glaxo Group Ltd PYRROLOPYRROLONES AS INHIBITORS OF NEUTROPHIL ELASTASE

Also Published As

Publication number Publication date
PE107899A1 (en) 1999-11-17
HUP0004644A3 (en) 2002-01-28
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
IL134791A0 (en) 2001-04-30
PL339176A1 (en) 2000-12-04
BR9812062A (en) 2000-09-26
EE200000138A (en) 2001-02-15
TR200000907T2 (en) 2000-11-21
IS5391A (en) 2000-02-29
KR20010023766A (en) 2001-03-26
NO20001198L (en) 2000-05-08
AU9741298A (en) 1999-03-29
CN1278820A (en) 2001-01-03
CA2303176A1 (en) 1999-03-18
NZ503130A (en) 2001-08-31
AR017072A1 (en) 2001-08-22
NO20001198D0 (en) 2000-03-08
HUP0004644A2 (en) 2001-09-28
WO1999012933A2 (en) 1999-03-18
AP2000001761A0 (en) 2000-03-31
EP1003748A2 (en) 2000-05-31
JP2001515904A (en) 2001-09-25
ID24452A (en) 2000-07-20
EA200000204A1 (en) 2000-10-30
CO4970719A1 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
BR9711970A (en) 6,5-substituted-heterobicyclic derivatives
FR2725204B1 (en) 2-HYDROXYPHENYLTRIAZINES AS PHOTOSTABILIZING AGENTS
FR07C0057I2 (en) PLEUROMUTILINE DERIVATIVES USED AS ANTIMICROBIAL AGENTS
DK0925298T3 (en) Substituted 6,6-heterobicyclic derivatives
NL350032I2 (en) Pyrazol-4-yl-benzoyl derivatives its use as herbicides
DE69705979D1 (en) Aqueous coating composition
DK1000048T3 (en) Substituted 1,2,3,4-tetrahydronaphthalane derivatives
DE69718771D1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
MA26543A1 (en) PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS.
PT921125E (en) DERIVATIVES OF 1,38-TRIAZA-ESPIRO 4,5 DECAN-4-ONA
MA26503A1 (en) 5'-DESOXY-CYTIDINE DERIVATIVES.
DE69938258D1 (en) 4,5-PYRAZINOXINDOLE AS PROTEIN KINASE INHIBITOR
MA26544A1 (en) PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS
EE03615B1 (en) Pyrazol-4-yl-hetaroyl derivatives as herbicides
PT1060183E (en) 5'-DESOXICITIDIN DERIVATIVES
MA26480A1 (en) PHENOXYMETHYLPIPERIDINE DERIVATIVES
ATE372989T1 (en) AZOLINE DERIVATIVES
TR28915A (en) Naftoquinone derivatives.
ATE243218T1 (en) 2''-DEOXYHYGROMYCIN DERIVATIVES
MA26481A1 (en) ARYLSECOCHOLADIAN DERIVATIVES
PT796843E (en) DERIVATIVES OF 1,25-DIHYDROXY-16,22,23-TRISDE-HYDRO-COLECALCIFEROL
NO993024D0 (en) The polysaccharide-peptide derivatives
ID16434A (en) COMPOUNDS OF 1,4-DIHYDROPIRIDINS
IT1295973B1 (en) PROCEDURE FOR LIGHTING OBJECTS.
KR960027979U (en) rake